Nutriflex Omega

Valine, Alanine, Arginine, Isoleucine, Leucine, Methionine, Phenylalanine, Proline, Serine, Threonin, the active ingredient in Nutriflex Omega, is an amino acid mixture presented as a parenteral nutrition solution for intravenous use. It supports metabolic needs in patients requiring comprehensive nutritional support, particularly in critical care and postoperative settings.

GNH USA supplies Nutriflex Omega as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Nutriflex Omega is an amino acid mixture used in parenteral nutrition to address protein and nitrogen requirements in several clinical situations. - Critical illness: helps meet increased protein needs and supports tissue repair. - Post‑operative recovery: provides essential amino acids for wound healing and muscle preservation. - Severe malnutrition: supplies a balanced amino acid profile when oral intake is insufficient. - Burn injuries: contributes to the high protein turnover required for skin regeneration. - Long‑term total parenteral nutrition (TPN): maintains nitrogen balance in patients dependent on intravenous feeding.

Adverse reactions to Nutriflex Omega are generally related to the intravenous route and the composition of the solution.

Common Side Effects: - Mild fever or chills during infusion. - Transient elevation of liver enzymes. - Electrolyte disturbances (e.g., mild hypernatremia). - Local irritation at the infusion site. - Nausea or vomiting.

Serious or Rare Side Effects: - Anaphylactic or severe hypersensitivity reactions. - Hyperosmolar metabolic acidosis. - Thrombophlebitis or catheter‑related bloodstream infection. - Severe electrolyte imbalance (e.g., hyperkalemia, hyperphosphatemia). - Renal impairment or acute kidney injury.

Nutriflex Omega should be administered under close clinical supervision, with attention to patient‑specific factors and laboratory monitoring.

- Renal function: assess baseline creatinine and adjust infusion rate if impaired. - Hepatic function: monitor liver enzymes, especially in patients with pre‑existing liver disease. - Electrolyte balance: check serum electrolytes before and during therapy. - Infusion rate: use recommended flow rates to avoid osmotic overload. - Compatibility: verify compatibility with other intravenous medications before co‑administration. - Store at ambient temperature: keep in original packaging, protect from moisture and direct sunlight.

Nutriflex Omega may interact with other intravenously administered agents, requiring careful coordination.

Major Interactions (Avoid): - Concurrent high‑dose potassium chloride: risk of severe hyperkalemia. - Acidifying solutions (e.g., sodium bicarbonate) mixed directly: can cause precipitation.

Moderate Interactions (Monitor Closely): - Loop diuretics: may exacerbate electrolyte shifts. - Insulin therapy: amino acids can stimulate insulin release, affecting glucose control. - Other parenteral nutrition components: ensure total nitrogen and caloric load remain within prescribed limits. - Anticoagulants: monitor coagulation parameters if central lines are used. - Vasopressors: observe for changes in hemodynamic response during infusion.